MAP2K7 and exanthem: Additionally, isotretinoin was also recommended in the management of other types of skin rashes induced by oncologic medications, such as epidermal growth factor inhibitors [7], BRAF inhibitors, MEK inhibitors, and mTOR inhibitors [8].